4.7 Review

Cervical cancer heterogeneity: a constant battle against viruses and drugs

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study

Pinar Bulutay et al.

Summary: Endocervical adenocarcinomas (ECAs) have been reclassified into HPVA and HPVI subtypes according to the International Endocervical Adenocarcinoma Criteria and Classification (IECC) adopted by WHO 2020. Most HPVA and HPVI can be easily classified based on the morphologic features, but the mitosis/apoptosis criteria may not be helpful in mucinous ECAs.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2022)

Article Multidisciplinary Sciences

Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions

John K. L. Wong et al.

Summary: Cancer driving mutations, especially in the non-coding part of the genome, are difficult to identify. In this study, researchers developed an algorithm called sigDriver to call driver mutations. They used a large dataset of tumor genome sequences and discovered multiple mutational processes associated with known and putative tumor drivers and hotspots, particularly in the non-coding regions of the genome, including APOBEC activity and somatic hypermutation signatures.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer

Zhengliang Li et al.

Summary: USP21 contributes to radio-resistance in cervical cancer cells through the FOXM1/Hippo signaling pathway, suggesting its potential as a target for radiosensitizers in radiotherapy.

HUMAN CELL (2022)

Review Microbiology

Human papillomaviruses: diversity, infection and host interactions

Alison A. McBride

Summary: HPVs are a diverse group of viruses that replicate in specific anatomical niches of the stratified epithelia. Most infections are asymptomatic, but some can cause benign proliferative lesions or even cancer. These viruses have evolved to evade the host immune system and manipulate cellular processes to ensure their survival and replication.

NATURE REVIEWS MICROBIOLOGY (2022)

Article Obstetrics & Gynecology

CircRNA VPRBP inhibits tumorigenicity of cervical cancer via miR-93-5p/FRMD6 axis

Lunhua Shen et al.

Summary: Circ_VPRBP inhibits cell proliferation, migration, and invasion and promotes cell apoptosis of cervical cancer cells by regulating the miR-93-5p/FRMD6 axis. The down-regulation of circ_VPRBP is observed in cervical cancer tissues and cells, and its overexpression leads to inhibition of proliferation and promotion of apoptosis in Caski and C33A cells. An interaction between Circ_VPRBP and miR-93-5p as well as the downstream target FRMD6 is identified, indicating their roles in cervical cancer progression. Additionally, in vivo experiments confirm that Circ_VPRBP suppresses tumor growth by regulating miR-93-5p and FRMD6.

REPRODUCTIVE SCIENCES (2022)

Article Oncology

High levels of chromosomal instability facilitate the tumor growth and sphere formation

Kenji Iemura et al.

Summary: Most cancer cells exhibit chromosomal instability (CIN), which may be a driving force for tumorigenesis. This study found that high-CIN cells grew more slowly in 2D culture but showed increased tumor formation and growth advantages in 3D culture and in vivo. High-CIN cells had higher karyotype heterogeneity, but this heterogeneity was reduced in formed spheres.

CANCER SCIENCE (2022)

Review Microbiology

Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities

Afra Basera et al.

Summary: Cervical cancer is a leading cause of female cancer fatalities in low-middle-income countries, with gaps in understanding the pathogenesis and the potential role of non-coding RNAs gradually being recognized.

MICROORGANISMS (2022)

Review Biochemistry & Molecular Biology

The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy

Lifang Zhang et al.

Summary: The PD-L1/PD-1 axis is associated with HPV-induced cervical cancer and plays a critical role in immune escape. Targeted therapies against this axis have potential efficacy in cervical cancer patients.

CURRENT MEDICINAL CHEMISTRY (2021)

Review Medicine, Research & Experimental

The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review)

Martha Laysla Ramos Da Silva et al.

Summary: Cervical cancer, caused by high-risk HPV infection, remains the second most common cancer type in women in developing regions. Epigenetic modifications are stable changes in DNA that affect gene expression and genomic stability, playing a key role in various biological processes. These modifications have been identified in both viral DNA and infected cell genomes, contributing to the development of cervical cancer.

BIOMEDICAL REPORTS (2021)

Article Oncology

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site

Maud Kamal et al.

Summary: This study analyzed the association between different viral integration signatures and clinical parameters in 272 cervical cancer patients, revealing MACROD2 gene as a hotspot of HPV integration. The type of viral integration was dependent on HPV genotype, and a high HPV copy number was associated with longer progression-free survival.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

HPV post-infection microenvironment and cervical cancer

Yi Yuan et al.

Summary: HPV infection is closely linked to cervical cancer, with the post-infection microenvironment (PIM) playing a crucial role in viral persistence and malignant progression. Targeting the PIM may be a potential strategy to enhance therapeutic outcomes for cervical cancer.

CANCER LETTERS (2021)

Article Pathology

Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations

Pier Selenica et al.

Summary: In this study, genetic alterations in a large cohort of gastric-type cervical adenocarcinomas (GCA) and other related adenocarcinomas were analyzed and compared. It was found that GCAs commonly harbor mutations in TP53, CDKN2A, KRAS, and STK11, and exhibit low levels of copy number alterations. GCAs show distinctive genetic mutation characteristics compared to other adenocarcinomas, with higher mutation frequencies in certain genes.

MODERN PATHOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer

Rina Masadah et al.

Summary: miRNAs play a fundamental role in the drug and radioresistance of cervical cancer, with evidence suggesting their potential application in clinical settings. Understanding the mechanisms by which miRNAs affect resistance and exploring new combined therapies could improve outcomes for cervical cancer patients.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

Stefan C. Dentro et al.

Summary: By extensively characterizing intra-tumor heterogeneity (ITH) across 2,658 cancer samples spanning 38 cancer types, this study found evidence of distinct subclonal expansions in nearly all informative samples, with frequent branching relationships between subclones. Positive selection of subclonal driver mutations was observed across most cancer types, indicating the importance of ITH and its drivers in tumor evolution.
Article Oncology

The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix

Xuan Pei et al.

Summary: Small cell neuroendocrine carcinoma of the cervix (SCNEC) is specifically associated with HPV 18 infection and characterized by a high genetic mutation rate, with mutations in genes related to the p53 pathway potentially affecting prognosis. Some patients harbor mutations in homogeneous recombination repair (HRR) genes, providing therapeutic targets. The study suggests that targeted therapies against certain mutated genes may have potential efficacy in SCNEC patients.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 via miR-206

Hui Hou et al.

Summary: The study revealed that miR-206 and OTUD6B-AS1 play important roles in cervical cancer cisplatin resistance. MiR-206 increases sensitivity by down-regulating CCND2, while OTUD6B-AS1 up-regulates CCND2 expression by sponging miR-206, and is associated with overall survival.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Detection of HPV and Human Chromosome Sites by Dual-Color Fluorescence In Situ Hybridization Reveals Recurrent HPV Integration Sites and Heterogeneity in Cervical Cancer

Jinfeng Xiong et al.

Summary: This study developed a dual-color FISH method to detect HPV integration sites in paraffin-embedded cervical cancer samples, revealing 3p14 and 8p14 as high-frequency HPV integration sites in cervical cancer. The study also identified heterogeneity within cervical cancer at the cellular level based on HPV integration.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Single-Cell RNA Sequencing Reveals Multiple Pathways and the Tumor Microenvironment Could Lead to Chemotherapy Resistance in Cervical Cancer

Meijia Gu et al.

Summary: This study comprehensively analyzed cell populations in cervical cancer tissues through single-cell RNA sequencing, identifying gene expression and functional differences between chemoresistant and chemosensitive patients, particularly in the PI3K/AKT pathway, which may contribute to chemotherapy resistance.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer

Shengjie Xu et al.

Summary: LSD1 knockdown can directly downregulate the expression of CD47 and PD-L1 through upregulating H3K4me2 levels, and the LSD1/p53/miR-34a signaling axis is also involved in the regulation of CD47/PD-L1 expression. In an established model, the combination of an LSD1 inhibitor with anti-CD47/PD-L1 monoclonal antibodies can more effectively inhibit tumor growth.

CELL DEATH & DISEASE (2021)

Article Chemistry, Medicinal

CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR

Mingqiang Dong et al.

Summary: Circular RNA circMYBL2 is upregulated in cervical cancer tissues and cells, especially in paclitaxel-resistant ones, and plays a crucial role in promoting paclitaxel resistance and malignant activities through the miR-665/EGFR network. Targeting circMYBL2 may represent a novel therapeutic strategy for cervical cancer patients resistant to paclitaxel.

DRUG DEVELOPMENT RESEARCH (2021)

Article Medicine, General & Internal

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

N. Colombo et al.

Summary: Adding pembrolizumab to chemotherapy significantly improves progression-free and overall survival in patients with persistent, recurrent, or metastatic cervical cancer when compared to placebo. Anemia and neutropenia are the most common grade 3 to 5 adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, Research & Experimental

Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in CC

Chunbo Li et al.

Summary: This study analyzed cells from CC and adjacent normal tissues using single-cell technologies, identifying different subpopulations in tumor cells and revealing the relationship between CSCs and tumor progression. Differences in gene expression between TECs and NECs were compared, and the potential biological function of ECs in vascularization was explored, highlighting the role of marker genes in facilitating connections between cancer cells and ECs.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Cell Biology

Identification of Biomarkers for Cervical Cancer Radiotherapy Resistance Based on RNA Sequencing Data

Yue Feng et al.

Summary: This study utilized bioinformatics methods to analyze a cervical cancer dataset, identifying 316 signature genes associated with poor response to radiotherapy, mainly involved in tumor immune responses. Through ranking with a random forest model, the top 30 candidate genes were selected, with 10 potential therapeutic targets identified for further investigation.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

Shiwen Peng et al.

Summary: Intratumoral vaccination with TA-CIN induces strong antigen-specific CD8 + T cell responses and antitumor effects. The vaccine generates a systemic immune response that can control distal tumors and induces tumor infiltration of CD8 + T cells. PD-1 blockade synergizes with intratumoral TA-CIN vaccination leading to enhanced CD8 + T cell responses and complete regression of tumors, providing rationale for future clinical testing.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Genetics & Heredity

Transcriptome sequencing profiles of cervical cancer tissues and SiHa cells

Tingting Chen et al.

FUNCTIONAL & INTEGRATIVE GENOMICS (2020)

Article Oncology

Small cell carcinoma of the uterine cervix: a multi-institutional experience

Junyun Li et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Review Cell Biology

Revising the WHO classification: female genital tract tumours

Ian A. Cree et al.

HISTOPATHOLOGY (2020)

Review Oncology

The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer

Maria Lina Tornesello et al.

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance

Andriy Marusyk et al.

CANCER CELL (2020)

Article Public, Environmental & Occupational Health

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

Marc Arbyn et al.

LANCET GLOBAL HEALTH (2020)

Review Biochemistry & Molecular Biology

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions

Masahiro Kagabu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Advances in immunotherapy for cervical cancer

R. Wendel Naumann et al.

CURRENT OPINION IN ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Single-cell transcriptomics in cancer: computational challenges and opportunities

Jean Fan et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Public, Environmental & Occupational Health

Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis

Zhuoru Zou et al.

Lancet Global Health (2020)

Article Medicine, General & Internal

Head and neck squamous cell carcinoma

Daniel E. Johnson et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Oncology

Biological and clinical aspects of HPV-related cancers

Klaudia Anna Szymonowicz et al.

CANCER BIOLOGY & MEDICINE (2020)

Article Oncology

Targeting HMGB3/hTERT axis for radioresistance in cervical cancer

Zongjuan Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Article Genetics & Heredity

Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity

Gabriela S. Kinker et al.

NATURE GENETICS (2020)

Review Genetics & Heredity

Resolving genetic heterogeneity in cancer

Samra Turajlic et al.

NATURE REVIEWS GENETICS (2019)

Review Pharmacology & Pharmacy

Biogenesis and Function of Circular RNAs in Health and in Disease

George Haddad et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Biotechnology & Applied Microbiology

Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing

Yamin Wang et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)

Article Oncology

RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer

Annapurna Pranatharthi et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Oncology

Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu

Ninu Maskey et al.

CANCER MANAGEMENT AND RESEARCH (2019)

Article Medicine, Research & Experimental

Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration

Yanqi Wen et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Obstetrics & Gynecology

CD44+/CD24+-Expressing Cervical Cancer Cells and Radioresistant Cervical Cancer Cells Exhibit Cancer Stem Cell Characteristics

Jun Zhang et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2019)

Review Oncology

Cervical Cancer, Version 3.2019

Wui-Jin Koh et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Article Oncology

An analysis of genetic heterogeneity in untreated cancers

Johannes G. Reiter et al.

NATURE REVIEWS CANCER (2019)

Article Oncology

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Camilla Lagheden et al.

BRITISH JOURNAL OF CANCER (2018)

Article Pharmacology & Pharmacy

Targeting EphA4 abrogates intrinsic resistance to chemotherapy in well-differentiated cervical cancer cell line

Shinichiro Kina et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2018)

Review Oncology

Opportunities and challenges for human papillomavirus vaccination in cancer

Richard B. S. Roden et al.

NATURE REVIEWS CANCER (2018)

Review Biochemistry & Molecular Biology

Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis

Shosuke Kawanishi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

News Item Oncology

Novel mutations in cervical cancer

Talha Khan Burki

LANCET ONCOLOGY (2017)

Article Multidisciplinary Sciences

Integrated genomic and molecular characterization of cervical cancer

Robert D. Burk et al.

NATURE (2017)

Review Oncology

Long non-coding RNAs on the stage of cervical cancer (review)

Junxue Dong et al.

ONCOLOGY REPORTS (2017)

Article Cell Biology

LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer

Hao-Zhe Cao et al.

CELL DEATH & DISEASE (2017)

Article Genetics & Heredity

Single-Cell mRNA Sequencing in Cancer Research: Integrating the Genomic Fingerprint

Soren Mueller et al.

FRONTIERS IN GENETICS (2017)

Review Oncology

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis

Darrell L. Ellsworth et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2017)

Review Biochemistry & Molecular Biology

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Nicholas McGranahan et al.

Review Obstetrics & Gynecology

Changing paradigms in the systemic treatment of advanced cervical cancer

Krista S. Pfaendler et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)

Article Genetics & Heredity

Identification of neutral tumor evolution across cancer types

Marc J. Williams et al.

NATURE GENETICS (2016)

Review Genetics & Heredity

Genetic drift, selection and the evolution of the mutation rate

Michael Lynch et al.

NATURE REVIEWS GENETICS (2016)

Review Chemistry, Medicinal

Molecular mechanisms of cisplatin resistance in cervical cancer

Haiyan Zhu et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2016)

Article Public, Environmental & Occupational Health

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

Laia Bruni et al.

LANCET GLOBAL HEALTH (2016)

Article Genetics & Heredity

Mechanistic signatures of HPV insertions in cervical carcinomas

Allyson Holmes et al.

NPJ GENOMIC MEDICINE (2016)

Article Biochemistry & Molecular Biology

Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells

B. Jiang et al.

GENETICS AND MOLECULAR RESEARCH (2015)

Article Oncology

Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women

Tony K. H. Chung et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Biochemistry & Molecular Biology

STAT3 correlates with stem cell-related transcription factors in cervical cancer

Hua Wang et al.

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2015)

Article Biochemistry & Molecular Biology

Toward understanding and exploiting tumor heterogeneity

Ash A. Alizadeh et al.

NATURE MEDICINE (2015)

Article Oncology

Adenocarcinoma of the Cervix: Should We Treat It Differently?

Ned L. Williams et al.

CURRENT ONCOLOGY REPORTS (2015)

Article Obstetrics & Gynecology

Variation in Apoptotic Gene Expression in Cervical Cancer Through Oligonucleotide Microarray Profiling

Ming-yue Zhu et al.

Journal of Lower Genital Tract Disease (2014)

Article Biochemistry & Molecular Biology

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability

Keiko Akagi et al.

GENOME RESEARCH (2014)

Article Multidisciplinary Sciences

Landscape of genomic alterations in cervical carcinomas

Akinyemi I. Ojesina et al.

NATURE (2014)

Review Medicine, General & Internal

Cytotoxic and Targeted Systemic Therapy in Advanced and Recurrent Cervical Cancer: Experience from Clinical Trials

Hyun-Joo Seol et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Article Oncology

Clinical significance of the stem cell gene Oct-4 in cervical cancer

Yanyan Yang et al.

TUMOR BIOLOGY (2014)

Review Genetics & Heredity

Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation

Reena V. Kartha et al.

FRONTIERS IN GENETICS (2014)

Review Pathology

Cellular Heterogeneity and Molecular Evolution in Cancer

Vanessa Almendro et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)

Article Oncology

A specific miRNA signature promotes radioresistance of human cervical cancer cells

Bin Zhang et al.

CANCER CELL INTERNATIONAL (2013)

Review Biochemistry & Molecular Biology

lincRNAs: Genomics, Evolution, and Mechanisms

Igor Ulitsky et al.

Review Multidisciplinary Sciences

Tumour heterogeneity and cancer cell plasticity

Corbin E. Meacham et al.

NATURE (2013)

Article Genetics & Heredity

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

Steven A. Roberts et al.

NATURE GENETICS (2013)

Article Obstetrics & Gynecology

Characterization of NOL7 Gene Point Mutations, Promoter Methylation, and Protein Expression in Cervical Cancer

Colleen L. Doci et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)

Article Multidisciplinary Sciences

Non-Random Integration of the HPV Genome in Cervical Cancer

Martina Schmitz et al.

PLOS ONE (2012)

Article Obstetrics & Gynecology

Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients

Joshua G. Cohen et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)

Article Oncology

cDNA MICROARRAY ANALYSIS OF SERIALLY SAMPLED CERVICAL CANCER SPECIMENS FROM PATIENTS TREATED WITH THERMOCHEMORADIOTHERAPY

Erling Dahl Borkamo et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)

Article Multidisciplinary Sciences

Somatic LKB1 Mutations Promote Cervical Cancer Progression

Shana N. Wingo et al.

PLOS ONE (2009)

Article Oncology

Natural history and epidemiology of HPV infection and cervical cancer

Xavier Castellsague

GYNECOLOGIC ONCOLOGY (2008)

Review Oncology

The natural history of cervical HPV infection: unresolved issues

Ciaran B. J. Woodman et al.

NATURE REVIEWS CANCER (2007)

Article Biochemistry & Molecular Biology

Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment

Alexander R. A. Anderson et al.

Article Oncology

Gene expression profiling in cervical cancer: An exploration of intratumor heterogeneity

Barbara Bachtiary et al.

CLINICAL CANCER RESEARCH (2006)

Review Microbiology

Pathogenesis of human papillomaviruses in differentiating epithelia

MS Longworth et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)

Article Medicine, General & Internal

Epidemiologic classification of human papillomavirus types associated with cervical cancer

N Muñoz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)